NNNN

Profile

Full Name

Anbio Biotechnology Class A Ordinary Shares

Ticker Symbol

NNNN

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

Germany

IPO

February 19, 2025

Indexes

Not included

Website

http://www.anbio.com

Employees

-

Key Details

Price

$7.27

Market Cap

$319.09M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$6.71M(-71.49% YoY)

Annual EPS

$0.02(-77.44% YoY)

PE Ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$7.27
NNNN price is $7.27

Price All-time High

$7.56
NNNN price is currently -3.84% below its historical high of $7.56

Price Most Recent Change

+3.86%
NNNN price was up +3.86% on Apr 3, 2025

Price YTD Change

-
NNNN price ytd change is unknown

Price 1-year Change

-
NNNN price 1-year change is unknown

Price 3-year Change

-
NNNN price 3-year change is unknown

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$319.09M
NNNN market capitalization is $319.09 million

Market Cap 3-year Change

-
NNNN market capitalization 3-year change is unknown

Market Cap All-time High

$331.82M
NNNN market capitalization is currently -3.84% below its historical high of $331.82 million

Market Cap Sector Rank

63.66%
NNNN market capitalization is higher than 63.66% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

-
NNNN shares outstanding 1-year change is unknown

Shares Outstanding 3-Year Change

-
NNNN shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.32
NNNN beta is 0.32

200-day SMA

$6.86
NNNN price is currently +5.92% above its 200-day simple moving average

50-day SMA

$6.86
NNNN price is currently +5.92% above its 50-day simple moving average

RSI

55.64
NNNN 14-day relative strength index is 55.64

Volume

0.23
NNNN 30-day relative volume is 0.23

ATR

$0.53
NNNN average true range is $0.53

10-day Historical Volatility

35.45%
NNNN 10-day historical volatility is 35.45%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$6.71M
NNNN annual revenue is $6.71 million

Revenue Analysts Estimate

-
NNNN annual revenue consensus analysts' forecast is unknown

Revenue 1-year Change

-71.49%
NNNN annual revenue is down -71.49% year-on-year

Revenue Sector Rank

-
NNNN annual revenue is unknown

EPS

EPS

$0.02
NNNN annual earnings per share is $0.02

EPS Analysts Estimate

-
NNNN annual earnings per share consensus analysts' forecast is unknown

EPS 1-year Change

-77.44%
NNNN annual earnings per share is down -77.44% year-on-year

EPS Sector Rank

-
NNNN annual earnings per share is unknown

Profit

Gross Profit

$3.36M
NNNN annual gross profit is $3.36 million

Gross Margin

50.07%
NNNN annual gross profit margin is 50.07%

Operating Profit

$1.96M
NNNN annual operating income is $1.96 million

Operating Margin

29.22%
NNNN annual operating profit margin is 29.22%

Net Income

$2.25M
NNNN annual net profit is $2.25 million

Net Margin

33.58%
NNNN annual net profit margin is 33.58%

Expenses

Total Expenses

$4.75M
NNNN annual total expenses is $4.75 million

Operating Expenses

$1.40M
NNNN annual total operating expenses is $1.40 million

Cost Of Goods Sold

$3.35M
NNNN annual cost of goods sold is $3.35 million

Selling, General & Administrative Expenses

$1.27M
NNNN annual SGA is $1.27 million

Depreciation And Amortization

$12.10K
NNNN annual depreciation & amortization is $12.10 thousand

Interest Expense

$0.00
NNNN annual interest expense is $0.00

Income Tax

$0.00
NNNN annual income tax is $0.00

EBIT & EBITDA

EBIT

$2.25M
NNNN annual earnings before interest & taxes is $2.25 million

EBITDA

$2.27M
NNNN annual EBITDA is $2.27 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$15.81M
NNNN annual total assets is $15.81 million

Non Current Assets

$62.10K
NNNN annual long term assets is $62.10 thousand

Current Assets

$15.75M
NNNN annual total current assets is $15.75 million

Cash And Cash Equivalents

$9.69M
NNNN annual cash & cash equivalents is $9.69 million

Accounts Receivable

$1.89M
NNNN annual accounts receivable is $1.89 million

Inventory

$0.00
NNNN annual inventory is $0.00

Liabilities

Total Liabilities

$993.10K
NNNN annual total liabilities is $993.10 thousand

Long Term Liabilities

$0.00
NNNN annual total long term liabilities is $0.00

Current Liabilities

$993.10K
NNNN annual total current liabilities is $993.10 thousand

Accounts Payable

$827.20K
NNNN annual accounts payable is $827.20 thousand

Debt

Total Debt

$0.00
NNNN annual total debt is $0.00

Total Debt 1-year Change

0%
NNNN {parameterFullLabel} has remained unchanged year-on-year

Long Term Debt

-
NNNN annual long term debt value is unknown

Short Term Debt

-
NNNN annual short term debt value is unknown

Equity & Capital

Shareholders Equity

$14.82M
NNNN annual stockholders equity is $14.82 million

Book Value

$14.82M
NNNN annual book value is $14.82 million

Retained Earnings

$14.80M
NNNN annual retained earnings is $14.80 million

Working Capital

$14.76M
NNNN annual working capital is $14.76 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

$898.40K
NNNN annual cash flow from operations is $898.40 thousand

Cash From Operations 1-year Change

-79.81%
NNNN annual cash flow from operations is down -79.81% year-on-year

Cash From Investing

$1.73M
NNNN annual cash flow from investing activities is $1.73 million

Cash From Investing 1-year Change

+213.24%
NNNN annual cash flow from investing activities is up +213.24% year-on-year

Cash From Financing

-$42.80K
NNNN annual cash flow from financing activities is -$42.80 thousand

Cash From Financing 1-year Change

-100%
NNNN annual cash flow from financing activities is down -100% year-on-year

CAPEX

CAPEX

-
NNNN annual capital expenditures value is unknown

CAPEX 1-year Change

-
NNNN annual capital expenditures 1-year change is unknown

Free Cash Flow

Free Cash Flow

$898.40K
NNNN annual free cash flow is $898.40 thousand

Free Cash Flow 1-year Change

-79.81%
NNNN annual free cash flow is down -79.81% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

50.07%
NNNN annual gross profit margin is 50.07%

Operating Margin

29.22%
NNNN annual operating profit margin is 29.22%

Net Margin

33.58%
NNNN annual net profit margin is 33.58%

ROA & ROE

ROA

15.14%
NNNN annual return on assets is 15.14%

ROE

16.47%
NNNN annual return on equity is 16.47%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
NNNN price to earnings ratio value is unknown

PE Ratio Sector Rank

-
NNNN price to earnings ratio is unknown

PB Ratio

PB Ratio

17.33
NNNN price to book ratio is 17.33

PB Ratio Sector Rank

96.39%
NNNN price to book ratio is higher than 96.39% of companies in Healthcare sector

PS Ratio

PS Ratio

-
NNNN price to sales ratio value is unknown

PS Ratio Sector Rank

-
NNNN price to sales ratio is unknown

Enterprise value

Enterprise Value

$308.78M
NNNN enterprise value is $308.78 million

Enterprise Value Sector Rank

63.63%
NNNN enterprise value is higher than 63.63% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
NNNN EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
NNNN EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

15.86
NNNN annual current ratio is 15.86

Quick Ratio

15.86
NNNN annual quick ratio is 15.86

Leverage

Debt To Equity

0.00
NNNN annual debt to equity ratio is 0.00

Interest Coverage Ratio

-
NNNN annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
NNNN piotroski f-score value is unknown

Altman Z-Score

196.11
NNNN altman z-score is 196.11

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

CVRX logo
CVRx (CVRX)
RNAC logo
Cartesian Therapeutics (RNAC)
TCMD logo
Tactile Systems Technology (TCMD)
Claritev (CTEV)
MPLN logo
MultiPlan (MPLN)
ALLO logo
Allogene Therapeutics (ALLO)
RGNX logo
REGENXBIO (RGNX)
HRTX logo
Heron Therapeutics (HRTX)
AMLX logo
Amylyx Pharmaceuticals (AMLX)
  • What is the ticker symbol for Anbio Biotechnology Class A?
  • Does Anbio Biotechnology Class A pay dividends?
  • What sector is Anbio Biotechnology Class A in?
  • What industry is Anbio Biotechnology Class A in?
  • What country is Anbio Biotechnology Class A based in?
  • When did Anbio Biotechnology Class A go public?
  • Is Anbio Biotechnology Class A in the S&P 500?
  • Is Anbio Biotechnology Class A in the NASDAQ 100?
  • Is Anbio Biotechnology Class A in the Dow Jones?
  • When does Anbio Biotechnology Class A report earnings?

What is the ticker symbol for Anbio Biotechnology Class A?

The ticker symbol for Anbio Biotechnology Class A is NASDAQ:NNNN

Does Anbio Biotechnology Class A pay dividends?

No, Anbio Biotechnology Class A does not pay dividends

What sector is Anbio Biotechnology Class A in?

Anbio Biotechnology Class A is in the Healthcare sector

What industry is Anbio Biotechnology Class A in?

Anbio Biotechnology Class A is in the Medical Instruments & Supplies industry

What country is Anbio Biotechnology Class A based in?

Anbio Biotechnology Class A is headquartered in Germany

When did Anbio Biotechnology Class A go public?

Anbio Biotechnology Class A's initial public offering (IPO) was on February 19, 2025

Is Anbio Biotechnology Class A in the S&P 500?

No, Anbio Biotechnology Class A is not included in the S&P 500 index

Is Anbio Biotechnology Class A in the NASDAQ 100?

No, Anbio Biotechnology Class A is not included in the NASDAQ 100 index

Is Anbio Biotechnology Class A in the Dow Jones?

No, Anbio Biotechnology Class A is not included in the Dow Jones index

When does Anbio Biotechnology Class A report earnings?

The next expected earnings date for Anbio Biotechnology Class A is May 30, 2025
On this page